The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there are multiple examples of people with elevated levels of apob that do not have accelerated atherosclerosis and I'm thinking specifically now of gsd1a which is Von giry's disease it's a glycogen storage disease it's a genetic defect in glucose uh glucose 6 phosphatase I believe and these people have elevated levels of apob and no accelerated atherosclerosis
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.